Effect of Dapagliflozin on Blood Pressure Variability in Patients With Prediabetes and Prehypertension Without Pharmacological Treatment

Trial Profile

Effect of Dapagliflozin on Blood Pressure Variability in Patients With Prediabetes and Prehypertension Without Pharmacological Treatment

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2018

At a glance

  • Drugs Dapagliflozin (Primary)
  • Indications Hypertension; Prediabetic-state; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Feb 2018 Planned End Date changed from 1 Nov 2017 to 1 May 2018.
    • 13 Feb 2018 Status changed from recruiting to active, no longer recruiting.
    • 03 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top